Patients who are using medications belonging to these lots should not interrupt treatment, but as soon as possible they should contact the doctor to evaluate the eventual need for replacement by an alternative medicine.
Pharmaceutical Generis, SA will volunteer with some lots of the sertraline generis 50 mg and 100 mg, film -coated compresses (multiple lots), as an impurity above the acceptable limit has been detected.
The manufacturer confirmed the presence of this quality defect in the indicated lots, so the immediate suspension of the commercialization of these lots determines:
| Registration number | Product | Batch | Expiration date |
| 4884888 | Sertraline generis 50mg 56cp rev | 23kn052a |
nov/25 |
| 4884680 | Sertralina type 50mg 14cp Rev | 23kn053Ap |
nov/25 |
| 4885182 | Sertralina type 100mg 56cp Rev | 23in031a |
set/25 |
| 4885182 | Sertralina type 100mg 56cp Rev | 23kn055a |
nov/25 |
| 4885182 | Sertralina type 100mg 56cp Rev | 24BN143A |
fev/26 |
| 4885182 | Sertralina type 100mg 56cp Rev | 24hn067a |
ago/26 |
| 4884888 | Sertraline generis 50mg 56cp rev | 23kn052B |
nov/25 |
| 4885182 | Sertralina type 100mg 56cp Rev | 23in032a |
set/25 |
| 4885182 | Sertralina type 100mg 56cp Rev | 23kn054a |
nov/25 |
Entities that have these plots of medicines in stock should return and cannot sell, dispense or administer them.
Patients who are using medications belonging to these lots should not interrupt treatment, but as soon as possible they should contact the doctor to evaluate the eventual need for replacement by an alternative medicine.
